PRELUDE CAPITAL MANAGEMENT, LLC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 394 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$236,000
-14.2%
5,341
-28.1%
0.01%0.0%
Q2 2022$275,000
+3337.5%
7,428
+4321.4%
0.01%
Q3 2020$8,000
-90.4%
168
-88.1%
0.00%
-100.0%
Q2 2020$83,000
+1283.3%
1,414
+1209.3%
0.01%
Q3 2019$6,000
-93.2%
108
-90.1%
0.00%
-100.0%
Q1 2019$88,000
+319.0%
1,087
+175.2%
0.01%
+400.0%
Q4 2018$21,000
-97.5%
395
-97.6%
0.00%
-97.9%
Q3 2018$834,000
+4533.3%
16,174
+4521.1%
0.05%
+4700.0%
Q4 2017$18,000
-98.9%
350
-98.9%
0.00%
-99.3%
Q3 2017$1,639,000
+606.5%
32,329
+607.4%
0.15%
+572.7%
Q2 2017$232,000
+15.4%
4,570
-8.7%
0.02%
+15.8%
Q1 2017$201,000
+74.8%
5,004
+107.3%
0.02%
+35.7%
Q4 2016$115,000
+721.4%
2,414
+536.9%
0.01%
+1300.0%
Q3 2016$14,000
-72.0%
379
-82.4%
0.00%
-85.7%
Q2 2016$50,000
-60.3%
2,155
-30.9%
0.01%
-61.1%
Q1 2016$126,000
-79.8%
3,118
-69.0%
0.02%
-81.4%
Q4 2015$624,00010,0680.10%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders